Pulmonary Embolism
& Anticoagulation Follow-Up
How to diagnose, treat, and follow up clots that travel to the lungs, and how to choose the right blood thinner and duration.
What Is a Pulmonary Embolism?
A pulmonary embolism (PE) is a blockage in one of the arteries of the lungs. Most often it begins as a deep vein thrombosis (DVT): a clot that forms in the deep veins of the legs and then breaks loose and travels through the heart to the lungs.
From Leg Vein to Lung Artery
How PE Presents
The Diagnostic Pathway
Start with the Wells score to estimate pretest probability. The strategy splits on probability:
Wells Score Decision Tree
Core Rule: Anticoagulate
Once PE is confirmed (or strongly suspected with stable vitals), the foundation of treatment is anticoagulation: blood thinners that stop new clot formation and let the body break down existing clot.
DOAC vs Warfarin
| DOAC | Warfarin | |
|---|---|---|
| Monitoring | None routine | INR checks |
| Target | Fixed dose | \( \text{INR} \, 2{-}3 \) |
| Onset | Rapid | Needs bridge |
| Pregnancy | Avoid | Avoid |
| Severe renal/APS | Avoid | Preferred |
How to Choose Duration
Anticoagulation Follow-Up
Example 1: Provoked PE
A 55-year-old man develops a confirmed PE 2 weeks after knee surgery. He is hemodynamically stable, with normal renal function and no bleeding history.
Example 2: Unprovoked PE
A 48-year-old woman has a first unprovoked PE, no surgery, no immobility, no cancer. Stable vitals, low bleeding risk on assessment.
Example 3: Massive PE
A 62-year-old woman with a large PE is hypotensive with \( \text{SBP} = 82 \,\text{mmHg} \) and signs of right heart strain on echo.
Common Mistakes
Duration Summary
| Scenario | Duration | Agent |
|---|---|---|
| Provoked, reversible | 3 months | DOAC |
| Unprovoked | Extended / indefinite | DOAC |
| Active cancer | While cancer active | DOAC / LMWH |
| Recurrent VTE | Indefinite | DOAC / warfarin |
| Pregnancy | Per pregnancy | LMWH |
Question 1 of 5
A patient has a high clinical probability of PE based on Wells score. What is the best next step?
Question 2 of 5
A stable patient with PE provoked by recent hip surgery and normal renal function should receive anticoagulation for how long?
Question 3 of 5
A PE patient with confirmed antiphospholipid syndrome needs anticoagulation. Which agent is preferred?
Question 4 of 5
A PE patient is hypotensive with \( \text{SBP} = 78 \,\text{mmHg} \) and right heart strain. Besides anticoagulation, what should be considered?
Question 5 of 5
A patient on a DOAC for PE returns for follow-up. Which lab is most important to monitor for safe dosing?